Fadini, Gian Paolo <br/><br/>
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.  [electronic resource] 

 -  Journal of the American Heart Association  07 2019 
 - e012244 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.119.012244  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Aged<br/>Angiotensin Receptor Antagonists--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Cardiovascular Diseases--complications<br/>Cholesterol, LDL<br/>Diabetes Mellitus, Type 2--complications<br/>Dual Anti-Platelet Therapy<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Heart Failure--complications<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypoglycemic Agents--therapeutic use<br/>Italy<br/>Male<br/>Metformin--therapeutic use<br/>Middle Aged<br/>Myocardial Infarction--complications<br/>Myocardial Ischemia--complications<br/>Myocardial Revascularization<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Sodium Potassium Chloride Symporter Inhibitors--therapeutic use<br/>Sodium-Glucose Transporter 2 Inhibitors--therapeutic use<br/>Glucagon-Like Peptide-1 Receptor Agonists